The PM, identified as the pathway with the highest count of differentially expressed metabolites, has been consistently reported in previous studies examining brain tissue samples from both APP/PS1 transgenic mice and deceased AD patients (González-Domínguez et al., 2015; Alonso-Andrés et al., 2018; Mahajan et al., 2020). This evidence concerns the gene APP and Alzheimer disease.